Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check6 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and makes a formatting adjustment to the Intervention/Treatment header.SummaryDifference0.3%

- Check13 days agoChange DetectedThe page revision label was updated to v3.5.5, indicating a small system or CMS update; no study text or data is changed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a maintenance update to the study entry without changing its substantive details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov “Revision” version (v3.5.3) instead of the previous one (v3.5.2), reflecting an administrative/site update rather than a change to the trial record.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision history updated: v3.5.0 was removed. v3.5.2 was added.SummaryDifference0.0%

- Check77 days agoChange DetectedHb SS disease added to related terms and Genetic and Rare Diseases Information Center added under Resources.SummaryDifference0.1%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.